newsfilter
← Latest News
FDA Approved Drugs·

Approval of Lithium Citrate, Anda #218036

Approval Date: 08/14/2023; Drug Name: Lithium Citrate, Anda #218036; Active Ingredients: LITHIUM CITRATE; Company: Rubicon; Submission Status: Approval; Application Number: 218036

Company
RUBICON
Keywords
RUBICON